Blaize Holdings (NASDAQ:BZAI) Stock

Blaize Holdings

Blaize Holdings Inc provides customized, programmable processor architecture suite, artificial intelligence (AI)-enabled edge computing solutions. The company is a semiconductor and software technology company dedicated to revolutionizing the world of AI.

Blaize Holdings Inc

News

Management

ICCC

ImmuCell Commences Search For President And CEO Successor

Nextracker Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>) has <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/b46090338/nextracker-selected-for-landmark-european-solar-power-project" rel="noreferrer noopener">expanded its global clean energy presence</a> by supplying its NX Horizon solar tracking systems to Greece&#8217;s largest solar installation, the 550 MW Oricheio PPC Ptolemaida Solar PV Park in Western Macedonia.
Led by PPC Renewables, a subsidiary of Greece&#8217;s state-owned PPC Group, the project repurposes a former coal mine into a clean energy hub. Once operational, the solar park is expected to generate nearly 1.8% of the country&#8217;s annual electricity supply.
Engineering firm Terna SA oversaw construction, implementing Nextracker&#8217;s technology to support Greece&#8217;s shift toward renewable energy. The project aligns with Greece&#8217;s revised National Energy and Climate Plan, which now aims for 82% of electricity generation from renewable sources by 2030, up from a previous goal of 66%.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/mid-cap/25/05/45613306/nextracker-bolsters-india-presence-with-10-gw-milestone-new-hyderabad-hub" rel="noreferrer noopener">Nextracker Bolsters India Presence With 10 GW Milestone, New Hyderabad Hub</a>
Nextracker President Howard Wenger called the project &#8220;an important step to increase energy independence in Europe and derisk capacity shortages for the region&#8221; and commended PPC and Terna for their high execution standards.
According to Wood Mackenzie, Nextracker leads the solar tracker market in Europe and globally, with more than 130 gigawatts of systems shipped. To meet rising demand, the company has expanded its local manufacturing partnerships across Europe, ensuring timely delivery and support for large-scale and distributed-generation projects.
Investors can also gain exposure to the solar sector via ETFs like Invesco Solar ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAN#NYSE">TAN</a>) and iShares Global Clean Energy ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLN#NASDAQ">ICLN</a>).
Price Action: NXT shares were trading lower by 0.017% to $57.25 premarket at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46089609/trump-administration-ordered-to-release-billions-in-ev-charger-funds-after-federal-judge-ruling" target="_blank" rel="noreferrer noopener">Trump Administration Ordered To Release Billions In EV Charger Funds After Federal Judge Ruling</a></li>
</ul>
Photo by fuyu liu via Shutterstock

Large Cap

ICLN

Nextracker's Tech Powers Greece's Largest Solar Park

Contracts

VERI

Veritone Awarded Sole Source Contract With Air Force Office of Special Investigations, Terms Not Disclosed

Corvus Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVS#NASDAQ">CRVS</a>), a clinical-stage biopharmaceutical company, today announced that the IND application submitted by its partner in&nbsp;China,&nbsp;Angel Pharmaceuticals Ltd.&nbsp;(Angel Pharma), has been approved by the&nbsp;Center for Drug Evaluation&nbsp;(CDE) of the&nbsp;China National Medical Products Administration&nbsp;(NMPA) to initiate a Phase 1b/2 clinical trial of soquelitinib for the treatment of patients with moderate-to-severe atopic dermatitis in&nbsp;China.
Corvus co-founded Angel Pharma to develop its pipeline in greater&nbsp;China.&nbsp;Angel Pharma licensed the rights from Corvus to develop, manufacture and commercialize soquelitinib in greater&nbsp;China and is responsible for all expenses related to its development in&nbsp;China.
Angel Pharma's Phase 1b/2 clinical trial for soquelitinib in patients with atopic dermatitis will build on the data previously presented by Corvus from its ongoing Phase 1 trial by studying a longer treatment period and an additional dosing option. The Phase 1b trial will be randomized, double-blinded, placebo-controlled and enroll patients with moderate-to-severe atopic dermatitis as follows:
<ul>
<li>Soquelitinib Cohort 1 (24 patients) – 8 patients receive placebo, 8 patients receive soquelitinib 100 mg twice per day and 8 patients receive soquelitinib 200 mg once per day</li>
<li>Soquelitinib Cohort 2 (24 patients) – 8 patients receive placebo, 8 patients receive soquelitinib 200 mg twice per day and 8 patients receive soquelitinib 400 mg once per day</li>
<li>The treatment period will be 12 weeks</li>
</ul>
The Phase 2 trial will also be a randomized, double-blinded, placebo-controlled study. It will enroll additional patients and focus on two doses that will be selected based on the safety and efficacy results from the Phase 1b trial.
The principal investigator of the Phase 1b/2 clinical trial is Yuling Shi, M.D, Ph.D. Dr. Shi is professor of dermatology, the Vice President of Shanghai Skin Disease Hospital at the Tongji University School of Medicine, and the founder and director of the Institute of Psoriasis at Tongji University School of Medicine, the first psoriasis institute in China. Dr. Shi has published more than 100 peer-reviewed articles, most focusing on psoriasis, skin autoimmunity, and inflammatory skin diseases.

CRVS

Corvus Says Partner Angel Pharma's IND Approved By CDE Of China NMPA To Initiate Phase 1b/2 Clinical Trial Of Soquelitinib For Treatment Atopic Dermatitis In China

WIIM

FedEx shares are trading lower following soft Q1 guidance.

Biotech

General

CRBP

Corbus Pharmaceuticals Doses First Patient With Nectin-4 Targeting ADC CRB-701 In Combination With Pembrolizumab

Asia Broadband Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AABB#OTC">AABB</a>) ("AABB" or the "Company") is pleased to announce that the Company has received a major delivery of additional production line processing equipment from China for the new facility in Etzatlan, Mexico, that opened recently in April 2025. AABB received 6 containers of equipment from manufacturer Mecru Heavy Industry Technology Co. Ltd. based in Zhengzhou, Henan, China, and the Company anticipates to receive the remaining 4 containers of equipment in early August. The new equipment is specifically for the Company's Phase 2 second line of production processing operations, which is expected to be installed and integrated sometime this year. Further details of the Phase 2 deliveries and operations will be announced in the coming weeks.
"Our new facility in Etzatlan just got stronger as the first delivery of our Phase 2 equipment arrived. Our team is thrilled to begin the preparations to amalgamate the Phase 2 line into the existing plant, which is already a game changer for our mining operations," expressed Chris Torres, AABB President and CEO.

AABB

Asia Broadband Announces Delivery Of Phase 2 Production Line Processing Plant Equipment From China Including 6 Containers Of Equipment And Anticipates 4 More In August 2025

Jones Trading analyst Catherine Novack maintains Capricor Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) with a Buy and lowers the price target from $40 to $29.

Price Target

Analyst Ratings

CAPR

Jones Trading Maintains Buy on Capricor Therapeutics, Lowers Price Target to $29

<h3>Gainers</h3>
<ul>
<li>Onfolio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONFO#NASDAQ">ONFO</a>) shares increased by 8.1% to $0.97 during Wednesday's pre-market session. The company's market cap stands at $4.6 million. </li>
<li>TEN Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHLD#NASDAQ">XHLD</a>) shares increased by 5.8% to $0.47. The market value of their outstanding shares is at $12.7 million. </li>
<li>Vivid Seats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEAT#NASDAQ">SEAT</a>) shares rose 5.69% to $1.75. The company's market cap stands at $215.5 million. </li>
<li>GD Culture Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDC#NASDAQ">GDC</a>) stock rose 5.47% to $3.47. The market value of their outstanding shares is at $55.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Fast Track (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRK#NASDAQ">FTRK</a>) stock declined by 11.6% to $2.21 during Wednesday's pre-market session. The market value of their outstanding shares is at $53.1 million. </li>
<li>VS Media Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSME#NASDAQ">VSME</a>) stock fell 11.22% to $0.95. The market value of their outstanding shares is at $47.9 million. </li>
<li>Intelligent Protection (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPM#NASDAQ">IPM</a>) shares fell 7.66% to $2.05. The market value of their outstanding shares is at $29.3 million. </li>
<li>Sound Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOGP#NASDAQ">SOGP</a>) shares decreased by 4.99% to $4.0. The company's market cap stands at $22.2 million. </li>
<li>AST SpaceMobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) shares decreased by 4.42% to $50.87. The market value of their outstanding shares is at $12.7 billion. </li>
<li>Brera Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BREA#NASDAQ">BREA</a>) stock decreased by 4.11% to $0.7. The company's market cap stands at $14.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ASTS

BREA

FTRK

ONFO

SEAT

SOGP

VSME

XHLD

10 Communication Services Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) shares increased by 87.2% to $0.35 during Wednesday's pre-market session. The company's market cap stands at $1.1 million. </li>
<li>Portage Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) stock increased by 22.67% to $6.6. The market value of their outstanding shares is at $12.2 million. </li>
<li>AEON Biopharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AEON#AMEX">AEON</a>) shares increased by 17.13% to $0.83. The company's market cap stands at $8.0 million. </li>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) shares increased by 17.13% to $31.24. The company's market cap stands at $693.8 million. </li>
<li>BioXcel Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTAI#NASDAQ">BTAI</a>) stock increased by 16.76% to $2.02. The company's market cap stands at $10.4 million. </li>
<li>Precision BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>) shares increased by 16.01% to $5.3. The market value of their outstanding shares is at $50.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>OneMedNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) stock fell 11.7% to $0.6 during Wednesday's pre-market session. The market value of their outstanding shares is at $20.8 million. </li>
<li>Forte Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBRX#NASDAQ">FBRX</a>) stock decreased by 11.01% to $12.61. The company's market cap stands at $93.2 million. </li>
<li>Trinity Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIB#NASDAQ">TRIB</a>) stock declined by 10.4% to $0.63. The market value of their outstanding shares is at $13.4 million. </li>
<li>InspireMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSPR#NASDAQ">NSPR</a>) stock declined by 10.31% to $2.22. The company's market cap stands at $75.8 million. </li>
<li>XTL Biopharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTLB#NASDAQ">XTLB</a>) stock declined by 9.17% to $1.19. The market value of their outstanding shares is at $11.5 million. </li>
<li>Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) shares fell 7.99% to $0.29. The company's market cap stands at $39.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEON

BTAI

DTIL

FBRX

LIMN

NSPR

ONMD

PRTG

PSTV

TRIB

XTLB

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>JVSPAC Acquisition (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JVSA#NASDAQ">JVSA</a>) stock rose 68.5% to $21.01 during Wednesday's pre-market session. The company's market cap stands at $95.8 million. </li>
<li>Expion360 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPON#NASDAQ">XPON</a>) stock increased by 10.66% to $0.99. The market value of their outstanding shares is at $3.0 million. </li>
<li>Worthington Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOR#NYSE">WOR</a>) shares rose 10.65% to $66.56. The market value of their outstanding shares is at $3.0 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>WF International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WXM#NASDAQ">WXM</a>) shares increased by 10.34% to $3.2. The company's market cap stands at $20.0 million. </li>
<li>ESS Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWH#NYSE">GWH</a>) stock moved upwards by 7.61% to $1.13. The market value of their outstanding shares is at $12.7 million. </li>
<li>New Horizon Aircraft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOVR#NASDAQ">HOVR</a>) shares increased by 6.62% to $1.93. The market value of their outstanding shares is at $56.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Globavend Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) shares declined by 20.0% to $1.0 during Wednesday's pre-market session. The market value of their outstanding shares is at $18.7 million. </li>
<li>OceanPal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) stock decreased by 7.47% to $1.86. The company's market cap stands at $15.0 million. </li>
<li>GrafTech International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAF#NYSE">EAF</a>) stock decreased by 5.61% to $1.01. The company's market cap stands at $276.1 million. </li>
<li>Perma-Pipe Inlt Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPIH#NASDAQ">PPIH</a>) shares fell 5.32% to $20.83. The market value of their outstanding shares is at $175.6 million. </li>
<li>Jet AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) stock declined by 4.95% to $3.65. The company's market cap stands at $9.7 million. </li>
<li>FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) shares declined by 4.8% to $218.5. The company's market cap stands at $54.9 billion. As per the press release, Q4 earnings came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HOVR

JTAI

JVSA

PPIH

XPON

12 Industrials Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Sonim Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>) shares moved upwards by 22.3% to $1.37 during Wednesday's pre-market session. The market value of their outstanding shares is at $11.5 million. </li>
<li>Thumzup Media (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZUP#NASDAQ">TZUP</a>) stock increased by 12.73% to $7.88. The company's market cap stands at $66.4 million. </li>
<li>Ondas Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) stock increased by 10.69% to $1.76. The market value of their outstanding shares is at $285.5 million. </li>
<li>MMTEC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) shares rose 10.17% to $1.01. The company's market cap stands at $23.2 million. </li>
<li>Aurora Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) stock moved upwards by 9.88% to $12.1. The company's market cap stands at $65.9 million. </li>
<li>Veritone (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERI#NASDAQ">VERI</a>) stock rose 9.73% to $1.49. The company's market cap stands at $63.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>XTI Aerospace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTIA#NASDAQ">XTIA</a>) stock fell 31.9% to $1.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $22.8 million. </li>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) shares declined by 13.21% to $0.65. The company's market cap stands at $5.2 million. </li>
<li>Wetouch Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETH#NASDAQ">WETH</a>) stock fell 8.11% to $0.85. The company's market cap stands at $10.9 million. </li>
<li>QXO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NYSE">QXO</a>) shares declined by 6.9% to $21.89. The market value of their outstanding shares is at $13.5 billion. </li>
<li>Iveda Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVDA#NASDAQ">IVDA</a>) shares declined by 5.48% to $1.9. The company's market cap stands at $5.6 million. </li>
<li>Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) stock fell 5.06% to $14.1. The market value of their outstanding shares is at $247.7 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IVDA

MOVE

ONDS

SONM

TZUP

WETH

XTIA

12 Information Technology Stocks Moving In Wednesday's Pre-Market Session

OVID

Ovid Therapeutics Enters Agreement with Immedica Pharma AB; Immedica To Pay $7M In Cash To Acquire 100% Of Royalty Ganaxolone Rights Held By Ovid

Advanced power management system will meet accelerating energy needs of data centers and cryptocurrency mining operations with real-time optimization, reduced peak loads and fast frequency response
Fort Lauderdale, FL, June 25, 2025 (GLOBE NEWSWIRE) -- MARA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>), a leading digital energy and infrastructure company, and TAE Power Solutions, a company commercializing proprietary power management systems derived from fusion energy research, today announced a strategic collaboration to jointly develop a high-frequency, real-time responsive load management system that can be modularly deployed up to GW scales, to meet the energy demand of hyperscale data centers, digital asset compute and other power-intensive industrial operations.

MARA

MARA And TAE Power Solutions Collaborate To Jointly Develop Real-Time Responsive Load Management System To Meet Energy Demand Of Data Centers And Cryptocurrency Mining Operations

DARE

Dare Bioscience Receives Nasdaq Panel Approval For Modified Compliance Plan; Faces July 31, 2025 Deadline To Avoid Delisting

AMRX

Amneal Pharmaceuticals Highlights Confirmatory Clinical Study Of ADL-018

Argus Research initiates coverage on Duolingo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOL#NASDAQ">DUOL</a>) with a Buy rating and announces Price Target of $575.

Initiation

DUOL

Argus Research Initiates Coverage On Duolingo with Buy Rating, Announces Price Target of $575

Energy Transfer Signs Incremental Sale and Purchase Agreement With Chevron For 1M Tonnes Per Annum

The Integrated Solution Supports the Explosion of AI Workloads with Owned and Operated Data Centers with Dedicated Power Generation
&nbsp;Sonim Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>), a leading provider of rugged mobile solutions, today announced the signing of a non-binding Letter of Intent (LOI) for a proposed reverse take-over (RTO) with a private US-based company (the "Target") building out Nvidia-based High-Performance Computing (HPC) A.I. factories to support the hyper growth of cloud-based artificial intelligence (AI) workloads.
Key terms of the proposed transaction include:
The LOI outlines the framework for a strategic business combination pursuant to which stockholders of the HPC A.I. factory Target would own a majority in the combined company.
Sonim stockholders would retain equity valued at $17.5 million in the combined company.
The HPC A.I. factory Target would be valued at approximately $300 million, with the valuation expected to be supported by a fairness opinion from an independent third party.
Following the closing, the combined company is expected to adopt a new corporate name and ticker symbol while maintaining its listing on Nasdaq.
Sonim believes that, when combined with the previously announced sale of substantially all of its operating assets for $15 million (plus an additional earn-out of $5 million), the proposed RTO transaction will maximize stockholder value and provide a compelling path forward for Sonim's strategic evolution. The Target is poised for significant growth by focusing on High-Performance Computing as a Service (HPCaaS). By leveraging their owned data centers, they aim to accelerate expansion, lower operational risks, and tap into the high-margin, fast-growing AI factory market. With plans to activate thousands of GPUs in 2025, they're positioning themselves to meet surging demand for the utility of the future, "Intelligence as a Service."
The global demand for AI-ready high-performance computing factory capacity is projected to grow at an average annual rate of 33% through 2030, with AI workloads driving up to 70% of total demand1. AI infrastructure spending is expected to exceed $200 billion by 2028, underscoring the transformative potential of this market2. To meet this surging demand, leading data center players are preparing to invest $1.8 trillion from 2024 to 2030, driven by traditional enterprise workloads (55% of demand in 2028) and the explosive growth of GenAI, which will account for 60% of total demand growth during this period3. In the U.S., initiatives such as Executive Order 14141 and a $500 billion private joint venture aim to bolster domestic AI infrastructure, with Congress emphasizing AI infrastructure as a strategic national asset4.
"This transaction positions Sonim stockholders to benefit from the tremendous growth of the AI revolution and represents a transformational step for Sonim and its stockholders," said Mike Mulica, Chair of the Special Committee for Sonim. "The RTO structure allows us to align with a forward-thinking partner in the AI and digital transformation space, leveraging their expertise to create a market-leading, technology-driven enterprise. At the same time, the CVR ensures our stockholders benefit from the successful transition of our legacy business."
The LOI is non-binding, and the transaction is further subject to customary closing conditions, regulatory approval, approval by Sonim stockholders and the completion of the Sonim Legacy Business Sale. The parties intend to finalize the definitive agreement and proceed with securing necessary approvals in a timely manner.

Sonim Technologies Announces Signing Of A Non-Binding Letter Of Intent For A Proposed Reverse Take-Over With A Private US-Based Company Building Out Nvidia-Based High-Performance Computing A.I. Factories Valued at ~$300M

MIRA Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRA#NASDAQ">MIRA</a>) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company focused on developing novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced new in vitro preclinical data generated by Eurofins supporting the therapeutic potential of SKNY-1, a next-generation oral drug candidate being developed by SKNY Pharmaceuticals, Inc. ("SKNY"). MIRA has signed a definitive agreement to acquire SKNY, and the proposed transaction remains subject to regulatory review and shareholder approval.
SKNY-1 is being developed to help individuals lose weight and quit smoking by targeting key biological pathways involved in appetite, addiction, and reward-without triggering the central nervous system (CNS) side effects that have historically limited cannabinoid-based therapies.
Market Outlook and Strategic Fit Obesity and smoking remain two of the world's leading causes of preventable death. The global obesity drug market is projected to surpass $150 billion in value by 2030, and the U.S. smoking cessation market is forecast to grow from $28 billion in 2024 to over $50 billion by decade's end.
Pending the completion of the proposed acquisition, MIRA believes SKNY-1 could become a cornerstone asset within its pipeline, offering a next-generation solution to two major health challenges. The Company is currently finalizing animal data related to weight loss and nicotine addiction, which will further support its development strategy and future regulatory filings.
MIRA has submitted the required regulatory filings to the U.S. Securities and Exchange Commission (SEC) in connection with the proposed acquisition of SKNY. A shareholder vote will follow in accordance with SEC regulations.

MIRA

MIRA Pharma Announces New In Vitro Preclinical Data Generated By Eurofins Supporting Therapeutic Potential Of SKNY-1, Next-Gen Oral Drug Candidate Being Developed By SKNY Pharma

Press Releases

Blaize Partners With KAIST to Create the Next Generation of Edge AI Technology

Blaize to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

Blaize Partners with Turbo Federal to Procure Contracts to Accelerate AI Solutions for the U.S. Department of Defense

Blaize Announces Fiscal Year 2024 Financial Results

Blaize and BroadSat Technologies Partner to Deliver AI-Powered Video Delivery and Compute at the Edge for Global Telecom and Smart City Infrastructure

CBIST Selects Blaize to Power its 2025 Smart City Development Project

Blaize to Report First Quarter 2025 Financial Results on May 14, 2025

Blaize Announces First Quarter 2025 Financial Results

Blaize to Participate at Upcoming Ladenburg Thalmann Technology Expo

Blaize to Attend D.A. Davidson 1st Annual Consumer & Technology Conference

BZAI

Alpha and Omega Semiconductor Limited - Common Shares

Alpha & Omega

CEVA

Canadian Solar

GCT Semiconductor Holding, Inc. Common Stock

GCT Semiconductor Hldgs

GSI Technology

Intchains Group Limited - American Depositary Shares

Intchains Gr

ChipMOS TECHNOLOGIES INC. - American Depositary Shares

ChipMOS TECHNOLOGIES

indie Semiconductor, Inc. - Class A Common Stock

Indie Semiconductor

JinkoSolar Holding Company Limited American Depositary Shares (each representing 4 Common Shares)

JinkoSolar Holding Co

Kopin

SEALSQ

Everspin Technologies, Inc. - Common Stock

Everspin Technologies

Magnachip Semiconductor Corporation Common Stock

MagnaChip Semiconductor

MaxLinear

Nano Labs

Navitas Semiconductor Corporation - Common Stock

Navitas Semiconductor

Penguin Solutions, Inc. - Ordinary Shares

Penguin Solutions

QuickLogic

SkyWater Technology

Sequans Communications S.A. American Depositary Shares (each representing ten (10) Ordinary Shares)

Comments

Blaize Holdings

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL